Latest Prescription Drugs news
Liso-Cel Has Favorable Safety Profile for Outpatients With Large B-Cell Lymphoma
posted October 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema
posted October 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Anti-TL1A Monoclonal Antibody, Tulisokibart, Aids Ulcerative Colitis
posted October 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Rheumatoid Arthritis Tied to Heavy Economic and Human Burdens
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
